![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif)
Public release date: 25-Mar-2011
[
| E-mail
| 
Share
]
Contact: Michele Sharp
Michele.Sharp@aacr.org
267-646-0622
American Association for Cancer Research
AACR awards AACR-Thomas J. Bardos Science Education Award for Undergraduate Students
ORLANDO, Fla. — The American Association for Cancer Research will recognize 27 recipients of the AACR-Thomas J. Bardos Science Education Award for Undergraduate Students at the AACR 102nd Annual Meeting 2011, held here from April 2 to 6.
The primary purpose of the AACR-Thomas J. Bardos Science Education Award for Undergraduate Students is to inspire science students at the undergraduate level to enter the field of cancer research.
The AACR is committed to promoting the education and training of the next generation of dedicated scientists, and to facilitating and nurturing their careers in cancer research or cancer-related biomedical science. Since its founding in 1997, AACR Science Education Awards have been supported by generous annual contributions from a distinguished member of the AACR, Dr. Thomas J. Bardos. His contributions are subsequently matched by those of AACR.
The recipients of the 2010-2011 AACR-Thomas J. Bardos Science Education Award for Undergraduate Students include:
- Krister J. Barkovich, University of California, Berkeley, Calif.
Abstract #2314. Erlotinib response in lung- and glioma-derived EGFR alleles: Correlating kinase site occupancy with efficacy
- Raul Caso, University of Miami, Coral Gables, Fla.
Abstract #449. Tumor microenvironment induces profound immune suppression: Macrophages from peripheral and tumor locations differ in their degrees of inflammatory impairment
- Kevin Chen, The College of New Jersey, Trenton, N.J.
- Dustin L. Gable, The Ohio State University, Columbus, Ohio
Abstract #3999. Ets1 as a target of microRNA-1 in cutaneous squamous cell carcinoma
- Daniel T. Huynh, University of the Pacific, Stockton, Calif.
Abstract #3401. The natural products, parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma
- Orli Kadoch, University of California, Davis, Calif.
- Elizabeth J. Kennedy, University of Michigan, Ann Arbor, Mich.
Abstract #1253. Metabolism and inflammatory breast cancer: Metabolic changes that occur with breast cancer progression
Abstract #1397. The effects of mevalonate pathway inhibitors on the motility and invasion of aggressive breast cancers
- Alan Kiang, University of California San Diego, La Jolla, Calif.
Abstract #4368. Targeting of head and neck cancer stem cells using salinomycin
- Natalie A. Vandeven, University of Michigan, Ann Arbor, Mich.
Abstract #1586. Oral administration of HIV-protease inhibitors reduces ovarian tumor growth in vivo
- Chaoying Sarah Xu, University of Toronto, Toronto, Ontario
Abstract #1973. Caveolin-1 promotes cell proliferation, EGFR activation and tumor growth in kidney cancer
The recipients of the 2011-2012 AACR-Thomas J. Bardos Science Education Award for Undergraduate Students include:
- Jeff Chen, University of California Davis, Davis, Calif.
Abstract #2462. Effects of KRASG12D and P53 oncogenes on pancreatic cellular plasticity
- Benjamin W. Dulken, University of Washington, Seattle, Wash.
Abstract #5293. Mixed micelles of triblock copolymers enhance delivery of indocyanine green for fluorescent tumor imaging
- Aurian P. Garcia-Gonzalez, University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico
Abstract #337. HPV16 infection plays a significant role in laryngeal carcinogenesis among Puerto Ricans
Abstract #3200. HPV status influences the survival of HNSCC patients: A consideration for the TNM staging system
- Allison Gomez, University of California San Diego, San Diego, Calif.
- Kelsey Gray, Ohio State University, Columbus, Ohio
- Akash Gupta, University of Louisville, Louisville, Ky.
Abstract #4619. Chemopreventive activities of the dark-color fruit 'jamun,' the Indian blackberry
- Nisan M. Hubbard, Virginia Commonwealth University, Richmond, Va.
- Thomas M. Kaffenberger, Ohio State University Medical Center, Columbus, Ohio
Abstract #909. Activation of NF-κB and its downstream targets play a key role in the dramatic induction of hepatocarcinogenesis in metallothionein null mice
- Steve L. Lu, The University of Texas MD Anderson Cancer Center, Austin, Texas
Abstract #2732. Short inverted repeats are hot spots for genetic instability in mammalian cells
- Ashwathi S. Mohan, Texas A&M University College of Science, College Station, Texas
- Melony A. Ochieng, North Carolina Central University, Durham, N.C.
- Emily E. Ortega, Johns Hopkins University, Baltimore, Md.
Abstract #1110. Differential expression of cholecystokinin receptors and their ligands in normal and neoplastic pancreas
- Daniel W. Sharp, Brigham Young University, Provo, Utah
Abstract #897. Thymidine kinase 1, a novel biomarker specific to the plasma membrane of cancerous cell lines
Abstract #3162. Assessing the therapeutic and diagnostic potential of human thymidine
kinase 1 in leukemia
Abstract #1678. Visualization of thymidine kinase 1 on the surface of cancer cell lines: A potential diagnostic marker and therapeutic target
- Daniel C. Sotelo, University of Arizona Cancer Center, Tucson, Ariz.
- Ken Tanaka, Amherst College, Amherst, Mass.
- Christopher A. Walker, University of Georgia, Athens, Ga.
Abstract #3868. Investigating biological mechanisms of breast cancer disparities: Basal-like specific gene expression
- Lian Zhu, University of Michigan Comprehensive Cancer Center, Ann Arbor, Mich.
Abstract #3842. RhoC is an essential determinant of breast cancer stem cell abundance and metastatic potential
###
Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world's oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.
[
| E-mail
| Share
]
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.